Related Experiment Video

Updated: Apr 1, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities

G Shay1, L Hazlehurst2, C C Lynch3

  • 1Tumor Biology Department, SRB-3, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Blvd, Tampa, FL, 33612, USA.

Journal of Molecular Medicine (Berlin, Germany)
|October 2, 2015
PubMed

Insights

Multiple myeloma remains incurable due to drug resistance and genetic heterogeneity. Targeting the bone microenvironment offers new therapeutic strategies to eradicate this plasma cell malignancy.

Area of Science:

  • Oncology
  • Hematology
  • Cancer Biology

Background:

  • Multiple myeloma is a plasma cell malignancy with limited curative options.
  • Current therapies like bortezomib and lenalidomide improve survival but face drug resistance.
  • Genetic heterogeneity of myeloma contributes to treatment failure.

Purpose of the Study:

  • To review recent advances in understanding the role of the bone microenvironment in myeloma progression.
  • To discuss therapeutic strategies targeting microenvironmental interactions for myeloma eradication.

Main Methods:

  • Literature review of current research on multiple myeloma and its microenvironment.
  • Analysis of therapeutic approaches targeting myeloma-bone marrow interactions.

Main Results:

  • The bone microenvironment critically influences myeloma progression.
  • Interactions between myeloma cells and hematopoietic/mesenchymal cells are key.
  • Targeting these microenvironmental elements shows therapeutic promise.

Conclusions:

  • Understanding myeloma-microenvironment interactions is crucial for developing new therapies.
  • Targeting the microenvironment offers a potential strategy to overcome drug resistance and cure multiple myeloma.
Keywords:
Bone microenvironmentMultiple myelomaTherapeutic opportunities

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.6K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K